doi: 10.1084/jem.85.6.623.
THE MODIFYING EFFECTS OF CERTAIN SUBSTANCES OF BACTERIAL ORIGIN ON THE COURSE OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM)
Affiliations
- PMID: 19871640
- PMCID: PMC2135676
- DOI: 10.1084/jem.85.6.623
Item in Clipboard
THE MODIFYING EFFECTS OF CERTAIN SUBSTANCES OF BACTERIAL ORIGIN ON THE COURSE OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM)
J Exp Med.
.
Abstract
Evidence is presented which indicates that certain polysaccharide preparations derived from various bacterial species, as well as similar materials not of bacterial origin, are capable of lessening the severity of infection with pneumonia virus of mice (PVM) and inhibiting multiplication of the virus in mouse lungs infected with this agent. It seems probable that modification with respect to the virus is mediated by a substance which may be polysaccharide in nature.
Similar articles
-
Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia.J Exp Med. 1951 Feb;93(2):161-71. doi: 10.1084/jem.93.2.161. J Exp Med. 1951. PMID: 14803640 Free PMC article.
-
Concurrent infection with influenza virus and mumps virus or pneumonia virus of mice as bearing on the inhibition of virus multiplication by bacterial polysaccharides.J Exp Med. 1949 Jan;89(1):37-52. doi: 10.1084/jem.89.1.37. J Exp Med. 1949. PMID: 18099164 Free PMC article.
-
The antagonistic effect of certain substances of bacterial origin on the course of infection with pneumonia virus of mice (PVM).Trans Assoc Am Physicians. 1947;60(1 vol):18-21. Trans Assoc Am Physicians. 1947. PMID: 18917237 No abstract available.
-
PROPERTIES OF PNEUMONIA VIRUS OF MICE (PVM) IN RELATION TO ITS STATE.J Exp Med. 1947 Jan 1;85(1):39-53. doi: 10.1084/jem.85.1.39. J Exp Med. 1947. PMID: 19871598 Free PMC article.
-
The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention.Pharmacol Ther. 2005 Jan;105(1):1-6. doi: 10.1016/j.pharmthera.2004.09.001. Pharmacol Ther. 2005. PMID: 15626452 Review.
Cited by
-
PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION.J Exp Med. 1948 Jan 1;87(1):1-9. doi: 10.1084/jem.87.1.1. J Exp Med. 1948. PMID: 19871694 Free PMC article.
-
INFLUENZA : I. THE HEMAGGLUTINATION AND INFECTIVITY TITRE CURVES OF PR8 INFLUENZA VIRUS CULTIVATED IN EMBRYONATED EGGS AT DIFFERENT TEMPERATURES.J Exp Med. 1950 Feb 28;91(3):321-9. doi: 10.1084/jem.91.3.321. J Exp Med. 1950. PMID: 19871708 Free PMC article.
-
[Protective effect of polysaccharide-like fractions of bacterial origin in an experimental virus infection].Experientia. 1956 Jun 15;12(6):213-4. doi: 10.1007/BF02170518. Experientia. 1956. PMID: 13330795 German. No abstract available.
-
The therapy of experimental influenza in mice with antibiotic lactones and related compounds.Yale J Biol Med. 1947 Jul;19(6):1017-22. Yale J Biol Med. 1947. PMID: 20261650 Free PMC article. No abstract available.
-
Chemotherapy of Virus Infections.Postgrad Med J. 1954 Jan;30(339):2. doi: 10.1136/pgmj.30.339.2. Postgrad Med J. 1954. PMID: 21313585 Free PMC article. No abstract available.
